Dynavax Technologies


Dynavax Technologies Stock Quote
$4.27 $0.19 4.7%
BATS BZX Real Time Price as of October 21, 2019, 4:00 p.m. EDT View Interactive DVAX Charts

A biopharmaceutical company that discovers and develops Toll-like Receptor 9 and agonist-based products to treat and prevent infectious diseases, allergies, cancer and chronic inflammatory.

News & Analysis: Dynavax Technologies

The Fool has written over 100 articles on Dynavax Technologies.


Market Moves


Is Dynavax Technologies a Buy?

Dynavax's stock surged higher in August. Can this small-cap biotech keep churning higher?

Interactive Chart